1'-(tert-Butoxycarbonyl)-4-oxospiro[chroman-2,4'-piperidine]-7-carboxylic acid
97%
- Product Code: 38708
CAS:
1086398-20-0
| Molecular Weight: | 361.3900 g./mol | Molecular Formula: | C₁₉H₂₃NO₆ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in the pharmaceutical and organic synthesis industries as a key intermediate in the development of various therapeutic agents. Its unique structure, featuring a spirocyclic system and a tert-butoxycarbonyl (Boc) protecting group, makes it valuable in the synthesis of complex molecules, particularly those targeting neurological and cardiovascular diseases. The Boc group can be selectively removed under mild conditions, allowing for further functionalization of the molecule. Additionally, the carboxylic acid moiety provides a handle for conjugation or modification, enabling the creation of derivatives with enhanced biological activity or improved pharmacokinetic properties. Its application extends to the design of protease inhibitors and other bioactive compounds, where the spirocyclic framework can mimic natural substrates or stabilize specific conformations.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | $367.50 |
+
-
|
1'-(tert-Butoxycarbonyl)-4-oxospiro[chroman-2,4'-piperidine]-7-carboxylic acid
This compound is primarily utilized in the pharmaceutical and organic synthesis industries as a key intermediate in the development of various therapeutic agents. Its unique structure, featuring a spirocyclic system and a tert-butoxycarbonyl (Boc) protecting group, makes it valuable in the synthesis of complex molecules, particularly those targeting neurological and cardiovascular diseases. The Boc group can be selectively removed under mild conditions, allowing for further functionalization of the molecule. Additionally, the carboxylic acid moiety provides a handle for conjugation or modification, enabling the creation of derivatives with enhanced biological activity or improved pharmacokinetic properties. Its application extends to the design of protease inhibitors and other bioactive compounds, where the spirocyclic framework can mimic natural substrates or stabilize specific conformations.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :